Phase I/II Study of SCTB39G in Advanced Solid Tumours

NCT07077252 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG: SCTB39G

Sponsor

Sinocelltech Ltd.